142 related articles for article (PubMed ID: 37052239)
1. Tilianin alleviates lipid deposition and fibrosis in mice with nonalcoholic steatohepatitis by activating the PPARα/Nnat axis.
Ke F; Wu X; Zheng J; Li C
Drug Dev Res; 2023 Aug; 84(5):922-936. PubMed ID: 37052239
[TBL] [Abstract][Full Text] [Related]
2. Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Zhang J; Zhang H; Deng X; Zhang N; Liu B; Xin S; Li G; Xu K
Life Sci; 2018 Jan; 192():46-54. PubMed ID: 29158052
[TBL] [Abstract][Full Text] [Related]
3. The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
Ren T; Zhu J; Zhu L; Cheng M
Nutrients; 2017 Feb; 9(3):. PubMed ID: 28264426
[TBL] [Abstract][Full Text] [Related]
4. Chaihu Guizhi Ganjiang Decoction attenuates nonalcoholic steatohepatitis by enhancing intestinal barrier integrity and ameliorating PPARα mediated lipotoxicity.
Wu H; Lou T; Pan M; Wei Z; Yang X; Liu L; Feng M; Shi L; Qu B; Cong S; Chen K; Yang H; Liu J; Li Y; Jia Z; Xiao H
J Ethnopharmacol; 2024 May; 326():117841. PubMed ID: 38310988
[TBL] [Abstract][Full Text] [Related]
5. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
6. A novel Alisma orientale extract alleviates non-alcoholic steatohepatitis in mice via modulation of PPARα signaling pathway.
Xie Y; Jin Y; Wen J; Li G; Huai X; Duan Y; Ni F; Fu J; Li M; Li L; Yan M; Cao L; Xiao W; Yang H; Wang ZZ
Biomed Pharmacother; 2024 Jul; 176():116908. PubMed ID: 38850668
[TBL] [Abstract][Full Text] [Related]
7. Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway.
Deng YF; Xu QQ; Chen TQ; Ming JX; Wang YF; Mao LN; Zhou JJ; Sun WG; Zhou Q; Ren H; Zhang YH
Phytomedicine; 2022 Sep; 104():154241. PubMed ID: 35749827
[TBL] [Abstract][Full Text] [Related]
8. Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe
Hua YQ; Zeng Y; Xu J; Xu XL
Phytomedicine; 2021 Jan; 81():153412. PubMed ID: 33234364
[TBL] [Abstract][Full Text] [Related]
9. [Effects of curcumol on liver function and fibrosis in rats of nonalcoholic fatty liver disease and its mechanism].
Qi SY; Huang H; Li YK; Pei LG; Zhang WJ
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):611-615. PubMed ID: 34821093
[No Abstract] [Full Text] [Related]
10. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway.
Ni XX; Li XY; Wang Q; Hua J
J Physiol Biochem; 2021 Feb; 77(1):35-45. PubMed ID: 33188625
[TBL] [Abstract][Full Text] [Related]
11. Silybin Alleviates Hepatic Steatosis and Fibrosis in NASH Mice by Inhibiting Oxidative Stress and Involvement with the Nf-κB Pathway.
Ou Q; Weng Y; Wang S; Zhao Y; Zhang F; Zhou J; Wu X
Dig Dis Sci; 2018 Dec; 63(12):3398-3408. PubMed ID: 30191499
[TBL] [Abstract][Full Text] [Related]
12. Hydrogen-rich water protects against liver injury in nonalcoholic steatohepatitis through HO-1 enhancement via IL-10 and Sirt 1 signaling.
Li SW; Takahara T; Que W; Fujino M; Guo WZ; Hirano SI; Ye LP; Li XK
Am J Physiol Gastrointest Liver Physiol; 2021 Apr; 320(4):G450-G463. PubMed ID: 33439102
[TBL] [Abstract][Full Text] [Related]
13. Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways.
Lee SM; Koh DH; Jun DW; Roh YJ; Kang HT; Oh JH; Kim HS
Clin Mol Hepatol; 2022 Oct; 28(4):827-840. PubMed ID: 35730208
[TBL] [Abstract][Full Text] [Related]
14. IκB kinase-beta inhibitor attenuates hepatic fibrosis in mice.
Wei J; Shi M; Wu WQ; Xu H; Wang T; Wang N; Ma JL; Wang YG
World J Gastroenterol; 2011 Dec; 17(47):5203-13. PubMed ID: 22215946
[TBL] [Abstract][Full Text] [Related]
15. Diallyl disulfide attenuates non‑alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, lipid peroxidation and inflammation in mice.
Zhang N; Wang Y; Zhang J; Liu B; Li G; Xin S; Xu K
Mol Med Rep; 2019 Aug; 20(2):1363-1372. PubMed ID: 31173200
[TBL] [Abstract][Full Text] [Related]
16. Lactoferrin Prevents Hepatic Injury and Fibrosis via the Inhibition of NF-κB Signaling in a Rat Non-Alcoholic Steatohepatitis Model.
Aoyama Y; Naiki-Ito A; Xiaochen K; Komura M; Kato H; Nagayasu Y; Inaguma S; Tsuda H; Tomita M; Matsuo Y; Takiguchi S; Takahashi S
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35010924
[TBL] [Abstract][Full Text] [Related]
17. Piperine alleviates nonalcoholic steatohepatitis by inhibiting NF-κB-mediated hepatocyte pyroptosis.
Ran S; Song L; Yang H; Yu J; Zhen Y; Liu Q
PLoS One; 2024; 19(3):e0301133. PubMed ID: 38547097
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rg5 inhibits lipid accumulation and hepatocyte apoptosis via the Notch1 signaling pathway in NASH mice.
Li N; Zhu C; Fu R; Ma X; Duan Z; Fan D
Phytomedicine; 2024 Feb; 124():155287. PubMed ID: 38176268
[TBL] [Abstract][Full Text] [Related]
20. Corosolic acid ameliorates non-alcoholic steatohepatitis induced by high-fat diet and carbon tetrachloride by regulating TGF-β1/Smad2, NF-κB, and AMPK signaling pathways.
Liu G; Cui Z; Gao X; Liu H; Wang L; Gong J; Wang A; Zhang J; Ma Q; Huang Y; Piao G; Yuan H
Phytother Res; 2021 Sep; 35(9):5214-5226. PubMed ID: 34213784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
